| Program | Indication | Preclinical | Phase 1 | Phase 2 | Phase 3 | Market |
|---|---|---|---|---|---|---|
| GATTEX (teduglutide) | Short Bowel Syndrome | |||||
| NPSP558 (parathyroid hormone 1-84 [rDNA origin] injection) | Hypoparathyroidism | |||||
| PREOS (parathyroid hormone 1-84 [rDNA origin] injection) | Osteoporosis | |||||
| Teduglutide | Crohn's Disease | |||||
| Glycine reuptake inhibitors | CNS | |||||
| Teduglutide | Pediatric Indications | |||||
| Teduglutide | GI Mucositis | |||||
| NPSP156 | CNS |
- Home
- About NPS
- R&D Pipeline
- Patients
- Partnered Portfolio
- Investors
- Careers
- Contact Us